Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer

NCT00753220 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Withdrew the IND with the FDA.

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: VDC2008
DRUG: Cyclophosphamide

Sponsor

Bostwick Laboratories

Collaborators

[object Object]
[object Object]
[object Object]